“…Recent approaches include the use of inactivated whole-virion vaccines (23), synthetic peptides (5,121,122), subunit vaccines (31,101,140), vector expression, recombinant live vector systems (23,102), infectious cDNA clone-derived vaccines (16,25,79,80,82,93,113), and naked DNA (24,84). The last two approaches appear to be the most promising.…”